Rare diseases
Investigational molecules
Locations
Study Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma
FranceStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids
FranceLong-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy of PRS-344/S095012 and obinutuzumab combination for patients with solid tumors - First human trial to evaluate safety and effectiveness
FranceStudy of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients
FranceStudy on the Effectiveness and Safety of Pirtobrutinib vs. Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma
FranceStudy on the Effects of Tacrolimus on Blood Sugar Levels in Patients Undergoing Dialysis Before Kidney Transplantation
FranceStudy on the Effectiveness of Lutetium (177Lu) Oxodotreotide and Octreotide in Patients with Advanced GEP-NET Tumors (Grade 2 and 3)
FranceStudy on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis
FranceStudy on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients
FranceStudy of Pirtobrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
FranceStudy on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
